SEC Cue Health Files for IPO for up to $100M The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020. Talis Biomedical 2020 Revenues Rise Sharply The company also said it is planning on filing for Emergency Use Authorization for its SARS-CoV-2 test in the second quarter of 2021. SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018. Abbott Enters $5B Credit Agreement Abbott has terminated its prior $5 billion credit agreement also with JP Morgan reached in November 2018. Hologic Raises Q4 Revenue Guidance The increased forecast is the result of continuing COVID-19 testing volumes along with recovery in its breast and skeletal business, Hologic said. Sep 9, 2020 Early Cancer Detection Firm Grail Files for IPO Aug 20, 2020 Aiming to Put Regulatory, Payor Issues in Past, Progenity Progresses With Women's Health Pipeline Premium Jun 16, 2020 Progenity Eyes $122.6M in Amended IPO Jun 15, 2020 Genetron Health Targeting $175.5M in Amended US IPO Jun 10, 2020 Danaher Replaces Previous $5B Credit Facility with New $2.5B Facility Jun 7, 2020 ArcherDx Targeting $100M in IPO Apr 27, 2020 SeqLL Withdraws Plans for $8M IPO Feb 12, 2020 OpGen Preliminary 2019 Revenues up 19 Percent Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Dec 17, 2019 Grail Raises $125M in Equity Financing Offering Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Oct 15, 2019 OpGen Plans $10.4M Stock, Warrant Sale Sep 4, 2019 Danaher Offering €6.20B in Senior Notes Aug 30, 2019 Danaher Enters Into $10B Loan Agreements Aug 28, 2019 OpGen Plans Reverse Stock Split Aug 13, 2019 Fulgent Genetics to Offer $75M of Securities Jul 10, 2019 Former Illumina Accountant Pleads Guilty to Insider Trading Mar 6, 2019 Invitae Expects to Raise at Least $171M in Common Stock Offering Mar 5, 2019 Invitae Launches $125M Common Stock Offering Mar 4, 2019 OpGen Files for $6.5M Public Offering of Common Stock Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.